Arovella Therapeutics Limited (ASX:ALA)
Australia · Delayed Price · Currency is AUD 0.0610
0.00 (0.00%)
Sep 11, 2026, 10:48 AM AEST
Arovella Therapeutics Market Cap
Arovella Therapeutics has a market cap or net worth of 73.74 million as of September 10, 2026. Its market cap has decreased by -21.53% in one year.
Market Cap
73.74M
Enterprise Value
59.39M
Revenue
3.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
ChartMarket Cap Chart
Since January 24, 2002, Arovella Therapeutics's market cap has increased from 17.67M to 73.74M, an increase of 317.20%. That is a compound annual growth rate of 5.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 73.74M | -33.99% |
| Dec 31, 2025 | 111.71M | -37.97% |
| Dec 31, 2024 | 180.10M | 72.28% |
| Dec 29, 2023 | 104.54M | 574.83% |
| Dec 30, 2022 | 15.49M | -17.41% |
| Dec 31, 2021 | 18.76M | 22.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 133.16M |
| Alterity Therapeutics | 110.34M |
| Recce Pharmaceuticals | 108.55M |
| Avecho Biotechnology | 88.87M |
| LTR Pharma | 84.53M |
| Entropy Neurodynamics | 68.57M |
| Prescient Therapeutics | 68.35M |
| Immutep | 67.79M |